NEW YORK (AP)- A major drug manufacturer has settled a suit by Alaska for $15 million related to health problems from a drug used by the state's Medidcaid system.
Alaska and Eli Lilly announced the settlement today in the state's lawsuit over the use of the drug Zyprexa.
The deal ensures that Alaska will be treated as well as any other state that may settle with Lilly over similar claims involving the drug, which is used to treat schizophrenia and bipolar disorder.
The agreement included no admission of wrongdoing by Lilly.
The state says Zyprexa-related health problems included weight gain, high blood sugar and diabetes.
The trial judge, speaking without the jury present earlier this month, said evidence presented by the state had established that the federal Food and Drug Administration "isn't capable of policing this matter."